Trade Windtree Therapeutics, Inc. - WINT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0570 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023457% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001235% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.1765 |
| Open | 1.1765 |
| 1-Year Change | -77.27% |
| Day's Range | 1.0965 - 1.1765 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 28, 2025 | 1.1065 | -0.0700 | -5.95% | 1.1765 | 1.1765 | 1.0865 |
| Apr 25, 2025 | 1.1765 | 0.0800 | 7.30% | 1.0965 | 1.2165 | 1.0965 |
| Apr 24, 2025 | 1.1365 | 0.0300 | 2.71% | 1.1065 | 1.1565 | 1.0665 |
| Apr 23, 2025 | 1.0965 | 0.1003 | 10.07% | 0.9962 | 1.1365 | 0.9962 |
| Apr 22, 2025 | 1.0365 | 0.0000 | 0.00% | 1.0365 | 1.0765 | 1.0165 |
| Apr 21, 2025 | 1.0265 | -0.0500 | -4.64% | 1.0765 | 1.0865 | 1.0165 |
| Apr 17, 2025 | 1.1165 | -0.0100 | -0.89% | 1.1265 | 1.1265 | 1.0765 |
| Apr 16, 2025 | 1.1265 | 0.0200 | 1.81% | 1.1065 | 1.1465 | 1.0265 |
| Apr 15, 2025 | 1.1465 | -0.2100 | -15.48% | 1.3565 | 1.4265 | 1.1465 |
| Apr 14, 2025 | 1.3165 | 0.0300 | 2.33% | 1.2865 | 1.3565 | 1.2865 |
| Apr 11, 2025 | 1.2565 | -0.0300 | -2.33% | 1.2865 | 1.3165 | 1.1965 |
| Apr 10, 2025 | 1.2965 | 0.0700 | 5.71% | 1.2265 | 1.4665 | 1.2265 |
| Apr 9, 2025 | 1.2965 | 0.0700 | 5.71% | 1.2265 | 1.3265 | 1.1765 |
| Apr 8, 2025 | 1.2865 | 0.0600 | 4.89% | 1.2265 | 1.3765 | 1.1265 |
| Apr 7, 2025 | 1.1565 | 0.0000 | 0.00% | 1.1565 | 1.2065 | 1.1165 |
| Apr 4, 2025 | 1.2665 | 0.1300 | 11.44% | 1.1365 | 1.6665 | 1.0865 |
| Apr 3, 2025 | 1.1865 | -0.1200 | -9.18% | 1.3065 | 1.3365 | 1.1865 |
| Apr 2, 2025 | 1.3065 | 0.1500 | 12.97% | 1.1565 | 1.3765 | 1.1165 |
| Apr 1, 2025 | 1.1565 | -0.1000 | -7.96% | 1.2565 | 1.2965 | 1.0465 |
| Mar 31, 2025 | 1.2165 | -0.2200 | -15.32% | 1.4365 | 1.4665 | 1.1965 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Windtree Therapeutics Inc. Company profile
About Windtree Therapeutics Inc
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company. The Company’s development programs are primarily focused on the treatment of acute cardiovascular and acute pulmonary diseases. The Company’s cardiovascular programs includes Istaroxime (Early Cardiogenic Shock), Istaroxime (acute heart failure), Rostafuroxin and Oral SERCA2a Activators. Its Pulmonary Programs include Lyophilized KL4 Surfactant and AEROSURF (aerosolized KL4 surfactant based on Aerosol Delivery System technology). The Company’s subsidiaries Discovery Laboratories, Inc., CVie Investments Limited and CVie Therapeutics Limited.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Windtree Therapeutics Inc revenues was not reported. Net loss increased from $25.1M to $54.6M. Higher net loss reflects Research and development - Balancing val increase of 8% to $11.1M (expense), Stock-based Compensation in R and D increase of 39% to $2.3M (expense), Stock-based Compensation in SGA increase of 21% to $3.4M (expense).
Equity composition
Common Stock $.015 Par, 04/11, 50M auth., 13,822,000 issd., less 21,000 shs. in Treas. @ $3.1M. Insiders own 1.88%. *NOTE: 12/97 Name changed from Ansan Pharmaceuticals; FY'00 Qs are restated. *2/05, PO 5.06M shares @ $5.75 by SG Cowen & Co., LLC. 12/10, 1-for-15 reverse split. 01/06, 1-for-14 reverse stock split
| Industry: | Biotechnology & Medical Research (NEC) |
2600 Kelly Rd Ste 100
WARRINGTON
PENNSYLVANIA 18976-3652
US
News
GME shares price forecast: Third-party price target
Read our GameStop (GME) share price forecast for 2025 and beyond, with insights from third-party analysts and market experts
11:40, 28 April 2025
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com